Protein engineering alters the polypeptide chain to obtain a novel protein with improved functional
properties. This field constantly evolves with advanced in silico tools and techniques to design novel proteins
and peptides. Rational incorporating mutations, unnatural amino acids, and post-translational modifications
increases the applications of engineered proteins and peptides. It aids in developing drugs with maximum efficacy
and minimum side effects. Currently, the engineering of peptides is gaining attention due to their high
stability, binding specificity, less immunogenic, and reduced toxicity properties. Engineered peptides are potent
candidates for drug development due to their high specificity and low cost of production compared with
other biologics, including proteins and antibodies. Therefore, understanding the current perception of designing
and engineering peptides with the help of currently available in silico tools is crucial. This review extensively
studies various in silico tools available for protein engineering in the prospect of designing peptides as
therapeutics, followed by in vitro aspects. Moreover, a discussion on the chemical synthesis and purification
of peptides, a case study, and challenges are also incorporated.